XML 42 R29.htm IDEA: XBRL DOCUMENT v3.21.1
License Agreements - Additional Information (Detail)
1 Months Ended 9 Months Ended 12 Months Ended
Aug. 31, 2016
USD ($)
Oct. 31, 2018
USD ($)
Sep. 30, 2017
USD ($)
Mar. 31, 2021
USD ($)
Jun. 30, 2020
USD ($)
May 31, 2020
USD ($)
Related Party Transaction [Line Items]            
Percentage of Purchase Requirement       100.00%    
License and supply agreement notice period       90 days    
Profit sharing ratio       0.5    
Receivable for foreign tax withholding       $ 20,420,000    
Kyowa Kirin Co            
Related Party Transaction [Line Items]            
Upfront payment   $ 10,000,000        
Total upfront payment receivable for grant of rights       100,000,000   $ 100,000,000
Receivable for foreign tax withholding       20,400,000    
Kyowa Kirin Co | Updation of Initial Assessment            
Related Party Transaction [Line Items]            
Estimated development cost sharing recovered through earnings       94,900,000    
Kyowa Kirin Co | Potential Payments on Achievement of Development Regulatory and Commercial Milestones            
Related Party Transaction [Line Items]            
Total upfront payment receivable for grant of rights         $ 10,000,000  
Kyowa Kirin Co | Potential Payments on Achievement of Development Regulatory and Commercial Milestones | Maximum            
Related Party Transaction [Line Items]            
Milestone payment receivable amount       582,500,000    
Helsinn License Agreement            
Related Party Transaction [Line Items]            
Compensation receivable for grant of rights $ 20,000,000          
Presage License Agreement | Presage Biosciences, Inc.            
Related Party Transaction [Line Items]            
Compensation payable for grant of rights     $ 4,900,000      
Payment for license     2,900,000      
Presage License Agreement | Presage Biosciences, Inc. | Incremental Payment            
Related Party Transaction [Line Items]            
Compensation payable for grant of rights     2,000,000      
Presage License Agreement | Presage Biosciences, Inc. | Potential Payments on Achievement of Development Regulatory and Commercial Milestones | Maximum            
Related Party Transaction [Line Items]            
Milestone payments payable amount     $ 179,000,000      
KKC License Agreement | Kyowa Kirin Co            
Related Party Transaction [Line Items]            
Upfront payment       100,000,000    
Transaction price relating to the performance obligation       191,500,000    
Expected milestone payment receivable       20,000,000    
Estimated development cost sharing recovered through earnings       66,300,000    
Deferred revenue       5,200,000    
KKC License Agreement | Kyowa Kirin Co | Ex US License            
Related Party Transaction [Line Items]            
Performance obligation revenue recognised         21,000,000  
License Obligation Account Transaction Price Allocated         64,500,000  
KKC License Agreement | Kyowa Kirin Co | Development Services            
Related Party Transaction [Line Items]            
Contract with customer liability non current       $ 25,400,000 $ 18,100,000